Advertisement

Topics

Families of Spinal Muscular Atrophy Company Profile

12:52 EDT 25th September 2017 | BioPortfolio

Families of Spinal Muscular Atrophy (FSMA) is dedicated to creating a treatment and cure by: funding and advancing a comprehensive research program; supporting SMA families through networking, information and services; improving care for all SMA patients; educating health professionals and the public about SMA; enlisting government support for SMA; embracing all touched by SMA in a caring community. FSMA's vision is a world where Spinal Muscular Atrophy is treatable and curable.


News Articles [1043 Associated News Articles listed on BioPortfolio]

Spinal Muscular Atrophy SMA Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Spinal Muscular Atrophy SMA Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Spinal Muscular Atrophy SMA in seven major markets US, France, Germany, Italy,...

Study unravels new clues to cause and treatment of spinal muscular atrophy

Spinal muscular atrophy, a neurodegenerative disease that causes progressive muscle wasting and paralysis, may be partly due to abnormalities in the synapses that connect sensory neurons and motor neu...

Spinal Muscular Atrophy SMA Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 31072017] Prices from USD $5750

DelveInsight's Spinal Muscular Atrophy SMA Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Spinal Muscular Atrophy...

Researchers seek biomarker to assess spinal muscular atrophy treatment

Spinal muscular atrophy (SMA) is the leading genetic cause of death in infants. As promising new therapies such as those directly targeting survivor motor neuron (SMN) are entering clinical trials for...

Spinal muscular atrophy: New clues to cause and treatment

Spinal muscular atrophy (SMA), a neurodegenerative disease that causes progressive muscle wasting and paralysis, may be partly due to abnormalities in the synapses that connect sensory neurons and mot...

Biogen Unveils More Study Data for Spinraza at SMA 2017

ArticleSpinal muscular atrophy is a genetic condition characterized by loss of motor neurons in the spinal cord and lower brain stem inducing severe and progressive muscular atrophy and weakness.

Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy

The authors show that in a mouse model of spinal muscular atrophy (SMA), there is a reduction in sensory synaptic drive that leads to motor neuron dysfunction and motor behavior impairments. SMA motor...

Spinal Muscular Atrophy SMA Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

DelveInsight's, Spinal Muscular Atrophy SMAPipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Spinal Muscular Atrophy SMA. The r...

PubMed Articles [2221 Associated PubMed Articles listed on BioPortfolio]

Symptom management and psychological support for families are the cornerstones of end-of-life care for children with spinal muscular atrophy type 1.

This study described end-of-life care for children affected by spinal muscular atrophy type 1 (SMA1), which is characterised by progressive muscle weakness and develops in the first six months of life...

Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy.

Duchenne muscular dystrophy (DMD) and Spinal muscular atrophy (SMA) causes significant disability and progressive functional impairment. Readily available instruments that assess functionality, especi...

Pregnancy and delivery in women with spinal muscular atrophy.

To expand the limited available knowledge about pregnancy and delivery in women with spinal muscular atrophy using a cohort of genetically proven SMA patients form USA.

Swallowing markers in spinal and bulbar muscular atrophy.

We examined the characteristics of dysphagia in spinal and bulbar muscular atrophy, a hereditary neuromuscular disease causing weakness of limb, facial, and oropharyngeal muscles via a videofluoroscop...

Patient-Identified Impact of Symptoms in Spinal and Bulbar Muscular Atrophy.

The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective, and the impact these symptoms have ...

Clinical Trials [2688 Associated Clinical Trials listed on BioPortfolio]

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

The primary objective of this study is to demonstrate a pharmacodynamic effect of CK-2127107 on measures of skeletal muscle function or fatigability in patients with Spinal Muscular Atroph...

A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular Atrophy

The purpose of this study is to evaluate the safety of olesoxime in participants with spinal muscular atrophy, focusing on the nature, frequency, and severity of adverse events, as well as...

Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy (SMA) is neurodegenerative disease of anterior horn cells of spinal cord and represents the second more frequent pathology in childhood. According to the age of ...

Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development

Spinal muscular atrophy (SMA) is the leading genetic cause of death of infants. Strong preclinical evidence suggests that effective therapy must be delivered as early as possible to preven...

A Study to Assess the Efficacy and Safety of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy

This study will test the Clinical Efficacy and Safety of ISIS-SMN Rx in patients with infantile-onset Spinal Muscular Atrophy.

Companies [853 Associated Companies listed on BioPortfolio]

Families of Spinal Muscular Atrophy

Families of Spinal Muscular Atrophy (FSMA) is dedicated to creating a treatment and cure by: funding and advancing a comprehensive research program; supporting SMA families through networking, informa...

Spinal Muscular Atrophy Foundation

Retrophin, LLC

Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is curr...

California Stem Cell, Inc.

California Stem Cell, Inc. is a privately held company focused on the manufacture of high-purity human cells for therapeutic development and screening applications. Since its foun...

PsychoGenics Inc.

PsychoGenics is a leader in preclinical behavioral neurobiology. The Company applies its behavioral expertise together with advances in robotics, computer vision, and informatics ...

More Information about "Families of Spinal Muscular Atrophy" on BioPortfolio

We have published hundreds of Families of Spinal Muscular Atrophy news stories on BioPortfolio along with dozens of Families of Spinal Muscular Atrophy Clinical Trials and PubMed Articles about Families of Spinal Muscular Atrophy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Families of Spinal Muscular Atrophy Companies in our database. You can also find out about relevant Families of Spinal Muscular Atrophy Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record